Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FN | APH |
|---|---|---|
| Price | $446.12 | $86.06 |
| Change today | ▲ 5.15% | ▲ 2.09% |
| Market cap | $15.99B | $212.22B |
| Return, 3 months | -18.5% | -0.1% |
| Return, year to date | -2.0% | +27.8% |
| Return, 1 year | +20.1% | +38.8% |
| P/E (TTM) | 34.2 | 43.0 |
| P/B | 6.5 | 13.7 |
| P/E percentile vs own 5y | 76th | 63rd |
| Dividend yield | – | 0.53% |
| Revenue growth (YoY, latest qtr) | +44.6% | +55.0% |
| Net profit growth (YoY) | +59.7% | +62.1% |
| Gross margin | 12.0% | 38.5% |
| Operating margin | 10.0% | 27.7% |
| Net margin | 10.2% | 17.7% |
| Return on equity | 21.3% | 38.1% |
| Analyst target vs. price | +67.5% | +17.0% |
| Analyst buy share | 86% | 89% |
| RSI (14) | 51 | 58 |
| 30-day volatility | 48.9% | 35.7% |
| Max drawdown, 1 year | -49.8% | -28.2% |
| Trend read | Mixed | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
